Kelly Schick - Chief People Officer at C4 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief People Officer
Stock Symbol
CCCC on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kelly Schick since 12/22/2023

Holdings reported by Kelly Schick for C4 Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 56.5K $341K $6.04 Nov 7, 2024 Direct
Performance Restricted Stock Units 10.5K $63.4K $6.04 Nov 7, 2024 Direct Common Stock
Stock Option (Right to Buy) 78.5K Mar 7, 2024 Direct Common Stock

Transactions reported by Kelly Schick for C4 Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.